Compugen Ltd.
General ticker "CGEN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $150.0M (TTM average)
Compugen Ltd. follows the US Stock Market performance with the rate: 37.4%.
Estimated limits based on current volatility of 3.4%: low 2.78$, high 2.98$
Factors to consider:
- Total employees count: 2271 as of 2002
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.17$, 2.66$]
- 2026-12-31 to 2027-12-31 estimated range: [1.45$, 3.10$]
Financial Metrics affecting the CGEN estimates:
- Positive: with PPE of 4.1 at the end of fiscal year the price was very low
- Positive: Operating cash flow per share per price, % of 22.34 > 12.96
- Positive: Operating profit margin, % of 43.05 > 18.52
- Negative: negative Industry operating income (median)
- Positive: Shareholder equity ratio, % of 65.49 > 64.25
- Positive: Investing cash flow per share per price, % of 21.18 > -0.65
- Positive: Return on assets ratio (scaled to [-100,100]) of 18.39 > 6.12
Short-term CGEN quotes
Long-term CGEN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $33.46MM | $27.86MM | $72.76MM |
| Operating Expenses | $46.45MM | $42.76MM | $41.44MM |
| Operating Income | $-12.99MM | $-14.89MM | $31.33MM |
| Non-Operating Income | $3.21MM | $5.18MM | $4.07MM |
| Interest Expense | $0.03MM | $0.03MM | $0.00MM |
| R&D Expense | $34.47MM | $24.81MM | $22.76MM |
| Income(Loss) | $-9.78MM | $-9.71MM | $35.40MM |
| Taxes | $8.97MM | $4.52MM | $0.05MM |
| Profit(Loss)* | $-18.75MM | $-14.23MM | $35.34MM |
| Stockholders Equity | $65.56MM | $54.91MM | $102.73MM |
| Assets | $121.33MM | $115.00MM | $156.87MM |
| Operating Cash Flow | $-35.89MM | $49.60MM | $31.63MM |
| Capital expenditure | $0.17MM | $0.12MM | $0.31MM |
| Investing Cash Flow | $35.51MM | $-46.25MM | $30.00MM |
| Financing Cash Flow | $3.08MM | $0.55MM | $10.60MM |
| Earnings Per Share** | $-0.21 | $-0.16 | $0.38 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.